SYK
Stryker Corporation
NYSE: SYK · HEALTHCARE · MEDICAL DEVICES
$315.13
+0.00% today
Updated 2026-04-30
Market cap
$120.69B
P/E ratio
37.47
P/S ratio
4.81x
EPS (TTM)
$8.41
Dividend yield
1.06%
52W range
$311 – $402
Volume
2.0M
Stryker Corporation (SYK) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $867.30M | $1.03B | $1.18B | $1.46B | $1.55B | $1.43B | $1.66B | $1.89B | $1.78B | $899.00M | $1.92B | $1.56B | $2.61B | $2.19B | $3.28B | $3.26B | $2.62B | $3.71B | $4.24B | $5.04B |
| Capital expenditures | $217.50M | $187.70M | $155.20M | $131.30M | $182.10M | $226.00M | $210.00M | $195.00M | $233.00M | $270.00M | $490.00M | $598.00M | $572.00M | $649.00M | $487.00M | $525.00M | $588.00M | $575.00M | $755.00M | $761.00M |
| Depreciation | $331.80M | $366.60M | $387.60M | $385.30M | $410.20M | $481.00M | $486.00M | $307.00M | $378.00M | $397.00M | $546.00M | $642.00M | $723.00M | $778.00M | $812.00M | $990.00M | $998.00M | $1.03B | $1.05B | $1.19B |
| Stock-based comp | $49.40M | $61.30M | $65.50M | $62.30M | $68.80M | $75.00M | $75.00M | $76.00M | $77.00M | $86.00M | $97.00M | $113.00M | $119.00M | $127.00M | $142.00M | $171.00M | $168.00M | $205.00M | $229.00M | $243.00M |
| Free cash flow | $649.80M | $840.60M | $1.02B | $1.33B | $1.37B | $1.21B | $1.45B | $1.69B | $1.55B | $629.00M | $1.43B | $961.00M | $2.04B | $1.54B | $2.79B | $2.74B | $2.04B | $3.14B | $3.49B | $4.28B |
| Investing cash flow | $-742.30M | $-1.18B | $310.10M | $-1.33B | $-795.50M | $-2.13B | $-736.00M | $-2.22B | $-1.88B | $1.96B | $-4.19B | $-1.61B | $-2.86B | $-1.46B | $-4.70B | $-859.00M | $-2.92B | $-962.00M | $-3.00B | $-4.87B |
| Financing cash flow | $-203.20M | $13.60M | $-1.05B | $-193.30M | $410.10M | $-161.00M | $-449.00M | $300.00M | $629.00M | $-1.14B | $2.26B | $-794.00M | $1.33B | $3.00M | $-11.00M | $-2.37B | $-749.00M | $-1.59B | $-525.00M | $113.00M |
| Dividends paid | $44.60M | $89.70M | $135.60M | $198.40M | $238.30M | $279.00M | $324.00M | $401.00M | $462.00M | $521.00M | $568.00M | $636.00M | $703.00M | $778.00M | $863.00M | $950.00M | $1.05B | $1.14B | $1.22B | $1.28B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-42.40M | $1.10B | $-853.00M | $490.00M | $-56.00M | $456.00M | $1.58B | $-63.00M | $-774.00M | $1.07B | $721.00M | $-1.44B | $39.00M | $-1.05B | — | — | — |